Key Takeaways
[ 1 ]
[ 2 ]
Alzheimer ’s disease develops over many years , long before symptoms are evident , but the lack of accessible , minimally invasive diagnostic test results in many people remain undiagnosed until the disease is well advanced , when few in force intervention remain .
“ This trial is a revolution in Alzheimer ’s disease both from a diagnostic and treatment degree of view , ” saysHoward Fillit , MD , a cofounder and the chief scientific military officer for theAlzheimer ’s Drug Discovery Foundation ( ADDF ) . “ Even as recently as 5 or 10 years ago , I never thought there would be a blood tryout for Alzheimer ’s disease , so this is really amazing progress . ”
Alzheimer’s Blood Test Was Highly Accurate in Clinical Trial
[ 3 ]
investigator found that most 92 percent of individuals who tested positive for amyloid plaque with the Lumipulse test also had grounds of amyloid plaque verified by PET scan or spinal rap .
Just over 97 percentage of those with negative solution from the Lumipulse test had a negative amyloid PET scan or spinal tap result .
Less than one - twenty percent of the 499 patients tested obtain an indeterminate Lumipulse termination .
The FDA noted that the Lumipulse blood test event were “ well tantamount ” to a similar , previously pass Lumipulse test that practice spinal tap samples .
Blood Test for Alzheimer’s Could Make Diagnosis Easier and More Readily Available
favored scan and spinal taps are extremely accurate when it come to discover amyloid plaques — but they are expensive , trespassing , time - consuming , and can have limited availability , agree to Dr. Fillit .
He gauge a lineage analysis like the Lumipulse test might cost $ 500 to $ 1,000 . A PET scan , by dividing line , can be as much as $ 6,000 to $ 8,000 . A blood draw is also far easier and less time - ware than learning ability imaging , and it does n’t bring out a affected role to radiation .
[ 4 ]
Monte Wiltse , president and CEO at Fujirebio Diagnostics , the manufacturer of the blood test , expects that the tool may help more people get an prescribed diagnosing sooner so they can receiveappropriate treatment , includingmedicationsthat can slow down Alzheimer ’s progression .
A Promising New Piece to the Diagnostic Puzzle
[ 5 ]
[ 6 ]
[ 7 ]
Increasingly , however , medical specialist in clinical preferences are using rip tests as a first - pass detection puppet . The Alzheimer ’s Association says that blood testing could become a more plebeian while of the symptomatic process , along with aesculapian history , neurologic test , and cognitive and functional appraisal .
It ’s still indecipherable how health care providers will incorporate the Lumipulse trial run into daily practice , according to Fillit .
“ There have been medical newspaper that treat this question : What encounter when a person gets a positive lineage test ? Do they necessitate a brain scan ? I do n’t remember that result has been amply resolved yet by organizations like the American Academy of Neurology and the American College of Physicians , ” he says .
“ This is just the beginning of a existent revolution of how diagnosis is going to be made . As blood line - based biomarkers retain to acquire , they will essentially reshape the landscape painting of Alzheimer ’s care , create a new landscape where preciseness medicine and prevention of the disease are possible , ” Fillit says .
New Blood Test May Prove Popular
[ 8 ]
Access to former discussion and aid is the independent reason reference for wanting a simple trial run .
Don Rauf has been a freelance wellness writer for over 12 years and his writing has been featured in HealthDay , CBS News , WebMD , U.S. News & World Report , Mental Floss , United Press International ( UPI),Health , and MedicineNet . He was previously a reporter for DailyRx.com where he covered stories tie in to cardiology , diabetes , lung cancer , prostate Crab , erectile dysfunction , change of life , and allergies . He has interviewed physician and pharmaceutic representatives in the U.S. and abroad .
He is a prolific writer and has written more than 50 books , includingLost America : Vanished Civilizations , Abandoned town , andRoadside Attractions . Rauf lives in Seattle , Washington .
alzheimer ’s disease
Sitting Too Much, Even if You Exercise, Could Raise Your Alzheimer’s Risk
Does Mild Cognitive Impairment (MCI) Lead to Dementia?
Alzheimer’s Disease Stages and How They Progress
Diet Changes to Make After an Alzheimer’s Diagnosis
Even Low-Key Exercise Is Fantastic for Your Brain
Delayed REM Sleep Linked to Higher Alzheimer’s Risk
A Day in the Life: Living With Early Alzheimer’s Disease
Doctors for Alzheimer’s Disease: Who Should Be on Your Healthcare Team?
Ozempic, Wegovy Tied to Lower Alzheimer’s Risk With Type 2 Diabetes
The Power of Music Therapy for Alzheimer’s
